Concepedia
Statistics
Publications
12
Citations
405
H-Index
11
Active since
2015
Affiliations
The Ohio State University(Current)
University of Cincinnati
Dana-Farber Cancer Institute
The Ohio State University Wexner Medical Center
The University of Texas MD Anderson Cancer Center
Cecelia Miller is an author at The Ohio State University specializing in medicine, oncology, and molecular oncology.
Publications per year
2015–2024
<i>TCL1</i> targeting <i>miR-3676</i> is codeleted with tumor protein p53 in chronic lymphocytic leukemia
Veronica Balatti, Lara Rizzotto, Cecelia Miller et al. · Proceedings of the National Academy of Sciences · 2015 · 73 citations · Full text
Medicine, Molecular Biology, Oncology +13
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib
Adam S. Kittai, Cecelia Miller, Daniel Goldstein et al. · Blood · 2021 · 61 citations
Medicine, Oncology, Pharmacotherapy +6
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL
Jennifer A. Woyach, Gabriela Perez Burbano, Amy S. Ruppert et al. · Blood · 2024 · 48 citations · Full text
Medicine, Geriatric Medicine, Pharmacology +2
Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib
Cecelia Miller, Amy S. Ruppert, Nyla A. Heerema et al. · Blood Advances · 2017 · 45 citations · Full text
Medicine, Hematology, Oncology +17
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study
Adam S. Kittai, David A. Bond, Ying Huang et al. · Journal of Clinical Oncology · 2024 · 43 citations
1–5 of 12